Chemoinformaics analysis of Butylated hydroxytoluene
| Molecular Weight | 220.356 | nRot | 0 |
| Heavy Atom Molecular Weight | 196.164 | nRig | 15 |
| Exact Molecular Weight | 220.183 | nRing | 1 |
| Solubility: LogS | -6.892 | nHRing | 0 |
| Solubility: LogP | 5.728 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 1 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
| nHA | 1 | APOL | 41.855 |
| nHD | 1 | BPOL | 24.077 |
| QED | 0.571 |
| Synth | 2.32 |
| Natural Product Likeliness | -1.265 |
| NR-PPAR-gamma | 0.987 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.006 |
| Pgp-sub | 0.008 |
| HIA | 0.004 |
| CACO-2 | -4.206 |
| MDCK | 0.0000091 |
| BBB | 0.015 |
| PPB | 1.01212 |
| VDSS | 1.935 |
| FU | 0.0138855 |
| CYP1A2-inh | 0.994 |
| CYP1A2-sub | 0.645 |
| CYP2c19-inh | 0.954 |
| CYP2c19-sub | 0.137 |
| CYP2c9-inh | 0.804 |
| CYP2c9-sub | 0.815 |
| CYP2d6-inh | 0.929 |
| CYP2d6-sub | 0.916 |
| CYP3a4-inh | 0.952 |
| CYP3a4-sub | 0.666 |
| CL | 2.019 |
| T12 | 0.002 |
| hERG | 0.038 |
| Ames | 0.327 |
| ROA | 0.15 |
| SkinSen | 0.22 |
| Carcinogencity | 0.339 |
| EI | 0.932 |
| Respiratory | 0.461 |
| NR-Aromatase | 0.19 |
| Antiviral | Yes |
| Prediction | 0.8283 |